🇺🇸 FDA
Patent

US 6015542

Radioimmunotherapy of lymphoma using anti-CD20 antibodies

expired A61KA61K2039/505A61K51/1069

Quick answer

US patent 6015542 (Radioimmunotherapy of lymphoma using anti-CD20 antibodies) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K51/1069